Intravenous versus subcutaneous immunoglobulin – Authors' reply

PATH study group

doi:10.1016/S1474-4422(18)30109-1

Intravenous versus subcutaneous immunoglobulin – Authors' reply

PATH study group

Neurology

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	393-394
Number of pages	2
Journal	The Lancet Neurology
Volume	17
Issue number	5
DOIs	https://doi.org/10.1016/S1474-4422(18)30109-1
State	Published - May 2018

Funding

Funders	Funder number
Dutch Prinses Beatrix Fonds
Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Access to Document

10.1016/S1474-4422(18)30109-1

Cite this

@article{e4504ab74b3e4c18af6c8201b1b95114,

title = "Intravenous versus subcutaneous immunoglobulin – Authors' reply",

author = "{PATH study group} and {van Schaik}, {Ivo N.} and Orell Mielke and Arman Sabet and Koshy George and Leslie Roberts and Ross Carne and Stefan Blum and Robert Henderson and {Van Damme}, Philip and Jelle Demeestere and Sandrine Larue and {Pinard D'Amour}, {Catherine Andree} and Vera Bril and Ari Breiner and Pavel Kunc and Martin Valis and Jana Sussova and Tomas Kalous and Radomir Talab and Michal Bednar and Toomas Toomsoo and Inna Rubanovits and Katrin Gross-Paju and Ulvi Sorro and Mika Saarela and Mari Auranen and Jean Pouget and Shahram Attarian and {Le Masson}, Gwendal and Wielanek-Bachelet, {Anne C{\'e}cile} and Claude Desnuelle and Emilien Delmont and Pierre Clavelou and Dominique Aufauvre and Jens Schmidt and Jana Zschuentssch and Claudia Sommer and Daniela Kramer and Olaf Hoffmann and Carsten Goerlitz and Judith Haas and Marko Chatzopoulos and Yoon, {Min Suk} and Ralf Gold and Peter Berlit and Andrea Jaspert-Grehl and David Liebetanz and Anna Kutschenko and Martin Stangel and Vivian Drory",

note = "Funding Information: INvS chairs a steering committee for CSL Behring and received departmental honoraria for serving on scientific advisory boards for CSL Behring and Baxter. He received departmental research support from The Netherlands Organization for Scientific Research and from the Dutch Prinses Beatrix Fonds. All lecturing and consulting fees for INvS were donated to the Stichting Klinische Neurologie, a local foundation that supports research in the field of neurological disorders. INvS serves on the editorial board of the Cochrane Neuromuscular Disease Group, is a member of the organising committee of the Inflammatory Neuropathy Consortium, a standing committee of the Peripheral Nerve Society, and is a member of the Scientific Board of the Kreuth III meeting on the optimal use of plasma-derived medicinal products, especially coagulation factors and normal immunoglobulins organised under the auspices of the European Directorate for the Quality of Medicines and HealthCare. OM is a CSL employee and programme director for the PATH study. We thank Michael Tortorici for the insights in the pharmacokinetic modeling and simulations. ",

year = "2018",

month = may,

doi = "10.1016/S1474-4422(18)30109-1",

language = "אנגלית",

volume = "17",

pages = "393--394",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "5",

}

TY - JOUR

T1 - Intravenous versus subcutaneous immunoglobulin – Authors' reply

AU - PATH study group

AU - van Schaik, Ivo N.

AU - Mielke, Orell

AU - Sabet, Arman

AU - George, Koshy

AU - Roberts, Leslie

AU - Carne, Ross

AU - Blum, Stefan

AU - Henderson, Robert

AU - Van Damme, Philip

AU - Demeestere, Jelle

AU - Larue, Sandrine

AU - Pinard D'Amour, Catherine Andree

AU - Bril, Vera

AU - Breiner, Ari

AU - Kunc, Pavel

AU - Valis, Martin

AU - Sussova, Jana

AU - Kalous, Tomas

AU - Talab, Radomir

AU - Bednar, Michal

AU - Toomsoo, Toomas

AU - Rubanovits, Inna

AU - Gross-Paju, Katrin

AU - Sorro, Ulvi

AU - Saarela, Mika

AU - Auranen, Mari

AU - Pouget, Jean

AU - Attarian, Shahram

AU - Le Masson, Gwendal

AU - Wielanek-Bachelet, Anne Cécile

AU - Desnuelle, Claude

AU - Delmont, Emilien

AU - Clavelou, Pierre

AU - Aufauvre, Dominique

AU - Schmidt, Jens

AU - Zschuentssch, Jana

AU - Sommer, Claudia

AU - Kramer, Daniela

AU - Hoffmann, Olaf

AU - Goerlitz, Carsten

AU - Haas, Judith

AU - Chatzopoulos, Marko

AU - Yoon, Min Suk

AU - Gold, Ralf

AU - Berlit, Peter

AU - Jaspert-Grehl, Andrea

AU - Liebetanz, David

AU - Kutschenko, Anna

AU - Stangel, Martin

AU - Drory, Vivian

N1 - Funding Information: INvS chairs a steering committee for CSL Behring and received departmental honoraria for serving on scientific advisory boards for CSL Behring and Baxter. He received departmental research support from The Netherlands Organization for Scientific Research and from the Dutch Prinses Beatrix Fonds. All lecturing and consulting fees for INvS were donated to the Stichting Klinische Neurologie, a local foundation that supports research in the field of neurological disorders. INvS serves on the editorial board of the Cochrane Neuromuscular Disease Group, is a member of the organising committee of the Inflammatory Neuropathy Consortium, a standing committee of the Peripheral Nerve Society, and is a member of the Scientific Board of the Kreuth III meeting on the optimal use of plasma-derived medicinal products, especially coagulation factors and normal immunoglobulins organised under the auspices of the European Directorate for the Quality of Medicines and HealthCare. OM is a CSL employee and programme director for the PATH study. We thank Michael Tortorici for the insights in the pharmacokinetic modeling and simulations.

PY - 2018/5

Y1 - 2018/5

UR - http://www.scopus.com/inward/record.url?scp=85045288528&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(18)30109-1

DO - 10.1016/S1474-4422(18)30109-1

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 29656738

AN - SCOPUS:85045288528

SN - 1474-4422

VL - 17

SP - 393

EP - 394

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 5

ER -

Intravenous versus subcutaneous immunoglobulin – Authors' reply

Funding

Access to Document

Other files and links

Cite this